NR4A2 and Parkinson disease: Another interesting finding of this study is the observed olfactory deficit in both MPTP-induced and αSyn overexpression models, and that 4A7C-301 (and CQ to a lesser degree) significantly rescued this deficit, suggesting the possibility that Nurr1 agonists may ameliorate at least some of the non-motor deficits of PD as well.